Back to Woodline Partners LP Woodline Partners LP

PRAXPRAX
9 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in PRAXIS PRECISION MEDICINES I

Yes. Woodline Partners holds 200,013 shares of PRAX (Praxis Precision Medicines), worth $67M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held PRAX since Q4 2024, across 7 quarterly 13F filings. PRAX is 0.2% of Woodline Partners' reported 13F portfolio.

Current Value

$67M

Current Shares

200,013

Total Value Change

+$65.3M

Total Shares Change

+172,750

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
200,013
0.0%
$67M0.2%$334.79
0
2026-Q1
Increased
200,013
+89.7%
$64.4M0.2%$318.22
56
2025-Q4
Decreased
105,412
-74.8%
$31.1M0.1%$297.02
0
2025-Q3
Increased
417,669
+808.9%
$22.1M0.1%$52.38
55
2025-Q2
Decreased
45,952
-73.8%
$1.9M0.0%$43.00
0
2025-Q1
Increased
175,727
+1666.5%
$6.7M0.0%$38.66
44
2024-Q4
New
9,948
-
$765,5980.0%$76.26
34
2024-Q2
Exited
0
-100.0%
$00.0%$41.36
0
2024-Q1
New
27,263
-
$1.7M0.0%$61.02
36

Other major holders of PRAX: Jupiter Topco LLC, Janus Henderson Group Ltd., Orbis Allan Gray Ltd, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used